Search clinical trials for: Ruxolitinib (JAKAVI®)
Total 14075 results
-
XenikosNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsTerminatedSteroid-Refractory Acute Graft Versus Host DiseaseUnited States, Belgium, Croatia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, Belgium, France, Israel, China, Japan, Italy, Germany, Taiwan, Poland, Austria, Finland, Hungary, Norway, Romania, Turkey
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post Essential Thrombocythemia Myelofibrosis | Post Polycythemia Vera MyelofibrosisUnited States, Spain, United Kingdom, Korea, Republic of, China, Japan, France, Turkey, Germany, Israel, Poland, Belgium, Italy, Austria, Denmark, Finland, Norway
-
Incyte CorporationTerminatedCRC (Colorectal Cancer)United States, France, United Kingdom, Spain, Israel, Australia, Germany, Korea, Democratic People's Republic of
-
Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisSpain, United States, France, Poland, Italy, Germany
-
Incyte CorporationTerminatedBreast CancerUnited States, France, United Kingdom, Spain, Italy, Portugal
-
Incyte CorporationTerminatedPancreatic CancerUnited States, Italy, United Kingdom, Belgium, Germany, Taiwan, Spain, Korea, Republic of, Canada, New Zealand, Australia, Thailand
-
Incyte CorporationTerminatedPancreatic CancerUnited States, France, Colombia, Israel, Portugal, Netherlands, Chile, Puerto Rico, Sweden, Austria, Denmark, Mexico, Ireland, Switzerland
-
Incyte CorporationTerminatedMPN (Myeloproliferative Neoplasms)United States
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsAvailable
-
Columbia UniversityIncyte CorporationActive, not recruitingAdvanced Cutaneous Squamous Cell CarcinomaUnited States
-
University Health Network, TorontoTerminatedCOVID-19 | PneumoniaCanada
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationCompletedMyelomonocytic LeukemiaUnited States
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Yi-Lun WangCompletedSteroid Refractory GVHDTaiwan
-
Novartis PharmaceuticalsNovartis is the Marketing Authorization Holder for Jakavi outside the US.No longer availableSevere/Very Severe COVID-19 Illness
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
The Lymphoma Academic Research OrganisationNovartisCompletedHodgkin's LymphomaFrance, Belgium
-
Oncology Institute of Southern SwitzerlandWithdrawn
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt... and other collaboratorsRecruitingAcute Myeloid Leukemia | Allogeneic Stem Cell Transplantation | Acute Myeloid Leukemia in RemissionUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteIncyte CorporationActive, not recruitingLeukemia | Chronic Myelomonocytic LeukemiaUnited States
-
University of California, San FranciscoIncyte CorporationCompleted
-
Washington University School of MedicineIncyte CorporationNo longer available
-
Sunnybrook Health Sciences CentreNovartisCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisGermany
-
Incyte CorporationRecruitingMyeloproliferative NeoplasmsSpain, Japan, France, Italy, Germany, Australia, United Kingdom, Denmark, Canada
-
French Innovative Leukemia OrganisationCompleted
-
Novartis PharmaceuticalsCompleted
-
Dana-Farber Cancer InstituteTerminated
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationTerminated
-
Washington University School of MedicineRigel PharmaceuticalsTerminatedMyelofibrosis | ThrombocytopeniaUnited States
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Sunnybrook Health Sciences CentreNovartisUnknownLeukemia, Lymphocytic, Chronic, B-CellCanada
-
Universitätsklinikum Hamburg-EppendorfNovartis; Clinical Trial Center North (CTC North GmbH & Co. KG)Active, not recruitingBone Marrow FibrosisGermany
-
Incyte CorporationCompletedAtopic DermatitisUnited States, Canada
-
Washington University School of MedicineIncyte CorporationWithdrawnCOVID-19
-
National Cancer Institute (NCI)TerminatedLeukemia, Adult T-Cell | T Cell Leukemia, Adult | T Cell Leukemia, HTLV I AssociatedUnited States
-
Novartis PharmaceuticalsCompletedPolycythemia Vera (PV)United States
-
M.D. Anderson Cancer CenterHelsinn Healthcare SACompletedMyeloproliferative DiseasesUnited States
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States